Prevalence of uropathogen producing extended spectrum beta lactamase (ESBL) at urinary tract infection in chronic kidney disease patients

Main Article Content

Carolin Wijaya
Anselmus Helbert Eriata
I Nengah Tony Rustawan
I Kadek Bayu Adhi Candra
Ni Nyoman Sri Budayanti

Keywords

urinary tract infection, extended spectrum beta lactamase (ESBL), chronic kidney disease

Abstract

Background: Urinary tract infection (UTI) is one of the most common bacterial infections encountered by clinicians in developing countries. UTI in patients with Chronic Kidney Disease (CKD) caused by ESBL-producing gram-negative bacteria has been increased in different countries. The common uropathogenic Gram negative bacteria are Escherichia coli and Klebsiella pneumoniae. The aim of this study was to identify prevalence of the common uropathogen producing ESBL E. coli and K. pneumonia among the patients with urinary tract infection (UTI) in chronic kidney disease as well as the susceptibility of antibiotic therapy.


Methods: This was a cross-sectional retrospective study to evaluate clinical urine isolates collected from Prof. Dr. I.G.N.G. Ngoerah Hospital within July 2019 until July 2020. Identification and susceptibility tests in urine isolate were performed by Vitex-2 System (Biomerieux) and interpreted with CLSI 2020 standard.


Results: From 1291 urine specimens,  210 urine specimens were collected (29.43%) from patients with UTI in CKD  during 12 months. Prevalence of uropathogen in chronic kidney disease from urine specimens were E.coli (41.57%), K.pneumoniae (13.15%), and Pseudomonas aeruginosa  (7.36%). It was found that ESBL produced E. coli (56.32%) and also K. pneumoniae (54%). Susceptibility antibiotic E. coli and K. pneumonia of UTI patient with CKD with ESBL producers were meropenem (99,10%), amikacin (98,07%), tigecycline (92,30%), gentamicin (80%), and fosfomycin (79,47%).


Conclusion: ESBL producers in patient UTI in CKD patients were E. coli 56,32%, K. pneumoniae 54% that were sensitive to meropenem, amikacin, tigecycline gentamicin, fosfomycin.

Abstract 385 | pdf Downloads 227

References

1. Pugalendhi S, Dutta TK, A clinical and microbiological profile of urinary tract infection in patients with chronic kidney diseases. Int J Adv Med. 2019;6(3):911.
2. Shankar M, Narasimhappa S, Madhura NS. Urinary Tract Infection in Chronic Kidney Disease Population: A Clinical Observational Study. 2021;13(1):1-9.
3. Arjumand M, Ali GMT, Dutta PK, Hassan MH, Hasan KMA, Barua BK. Pattern of UTI in Chronic Kidney Disease: Experience from A Tertiary Care Hospital, Bangladesh. Chattagram Maa-O-Shishu Hosp Med Coll J. 2021;20(1).
4. Salih NI, Raad AZ, Yaseen LQ, Malik WA. Bacteriological and Immunological Study of Chronic Failure Patients Undergoing for Hemodialysis. Clin Schizophr Relat Psychoses. 2021;15.
5. Lee HL, Whang DH, Park DW, et al. Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum β-Lactamase in Patients on Renal Replacement Therapy. J Korean Med Sci. 2013;28(8):1187-1193.
6. Rezia RA, Vijendra R, Gopi A. Uropathogens Causing Urinary Tract Infection in Adults in a Tertiary Care Hospital. Published online 2020:9-14.
7. Ndzime YM, Onanga R, Kassa RFK, et al. Epidemiology of community origin Escherichia coli and Klebsiella pneumoniae uropathogenic strains resistant to antibiotics in Franceville, Gabon. Infect Drug Resist. 2021;14:585-594.
8. Abalkhail A, AlYami AS, Alrashedi SF, et al. The Prevalence of Multidrug-Resistant Escherichia coli Producing ESBL among Male and Female Patients with Urinary Tract Infections in Riyadh Region, Saudi Arabia. Healthcare (Basel). 2022;10(9):1778.
9. Foxman B. The epidemiology of urinary tract infection. Nat Publ Gr. 2010;7(12):653-660.
10. Sukrama IDM, Pinatih KJP, Hendrayana MA, Rasyid B, Wedari NLPH. Escherichia coli Clonal Variability Based on Genetic Diversity Pattern with Enterobacterial Repetitive Intergenic Consensus-Polymerase Chain Reaction Methods for Traveler’s Diarrhea Cases in Bali. Open Access Maced J Med Sci. 2022;10(A):752-60.
11. Kayastha K, Dhungel B, Karki S, et al. Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species in Pediatric Patients Visiting International Friendship Children's Hospital, Kathmandu, Nepal. Infect Dis (Auckl). 2020;13:1178633720909798.
12. T Jia P, Zhu Y, Li X, et al. High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study. Front Microbiol. 2021;12:663033.
13. Chowdhury S, Chakraborty P. Universal health coverage ‑ There is more to it than meets the eye. J Fam Med Prim Care. 2017;6(2):169-170.
14. Ali S, Yousef A, Younis S, Farrag E, Moussa HS, Bayoumi FS. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae. 2016;46(4).
15. Wedari NLPH, Sukrama IDM, Budayanti NNS, Sindhughosa DA, Prabawa IPY, Manuaba IBAP. One Health concept and role of animal reservoir in avian influenza: a literature review. Bali Medical Journal. 2021;10(2): 515-520.
16. Dimitrijevic Z, Paunovic G, Tasic D, Mitic B, Basic D. Risk factors for urosepsis in chronic kidney disease patients with urinary tract infections. Sci Rep. 2021;11(1):1-8.